Clinical Trials Directory

Trials / Completed

CompletedNCT01856530

Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder

Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Stefan G. Hofmann · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn more about how the hormone, oxytocin, impacts social behavior in terms of cooperation with others, attention processing, and reward processing, among patients with social anxiety disorder. Based on available research, the investigators predict that in patients with social anxiety disorder, oxytocin will improve social cooperation during an online ball-tossing game called Cyberball, reduce attention toward socially threatening cues during a dot-probe task, and lead to greater willingness to work for monetary rewards for others rather than themselves during an effort expenditure task.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinLiquid metered-dose nasal spray, 24 IU, administered once
DRUGPlaceboMatched placebo nasal spray

Timeline

Start date
2012-07-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-05-17
Last updated
2018-02-13
Results posted
2014-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01856530. Inclusion in this directory is not an endorsement.